Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001045109 | SCV001208943 | pathogenic | Ellis-van Creveld syndrome; Curry-Hall syndrome | 2023-10-25 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Gln879*) in the EVC gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in EVC are known to be pathogenic (PMID: 23220543). This variant is present in population databases (rs121908424, gnomAD 0.003%). This premature translational stop signal has been observed in individual(s) with Ellis-van Creveld syndrome (PMID: 10700184). ClinVar contains an entry for this variant (Variation ID: 5339). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. For these reasons, this variant has been classified as Pathogenic. |
Fulgent Genetics, |
RCV001045109 | SCV005662720 | pathogenic | Ellis-van Creveld syndrome; Curry-Hall syndrome | 2024-06-13 | criteria provided, single submitter | clinical testing | |
OMIM | RCV000005667 | SCV000025849 | pathogenic | Ellis-van Creveld syndrome | 2000-03-01 | no assertion criteria provided | literature only | |
Natera, |
RCV000005667 | SCV002083058 | pathogenic | Ellis-van Creveld syndrome | 2021-07-21 | no assertion criteria provided | clinical testing |